Conversations in Science with the Disruptors Leading the Way
Click the gear icon for captions in other languages.
An Open Science Approach to Developing Childhood Cancer Drugs
Operating under Open Science principles enables M4K to partner with a range of organizations that contribute their scientists’ expertise and research services. M4K’s current funding comes from government grants and donations, with Charles River and other companies performing pro bono research to help deliver drug candidates.
About 190 Charles River employees have volunteered time so far, adding up to over 13,000 hours of work. All of our contributions to M4K are a part of our commitment to Global Corporate Citizenship and Community Impact.
Open Science: The Parallel Universe
Join Vital Science™ hosts Gina Mullane and Chris Garcia with Aled Edwards to discusses the concept of “open science” and how it can accelerate drug development.
Listen to The Podcast